Suppressor cell function inhibition following Listeria vaccine treatment
US10058599B2 · kind B2 · utility
6Cited by
89References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2013 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Mar 12, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides methods and compositions for using a live attenuated Listeria for inhibiting cell-mediated suppression of anti-disease infiltrating T lymphocytes in a subject having the disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.